# MSA Safety Inc: Form 10-Q for the period ended Jun 30, 2018

- Company: [MSA Safety Inc](/companies/msa.md) (CIK 66570)
- Form: 10-Q
- Filed: 2018-07-26
- Accepted by EDGAR: Jul 26, 2018, 15:38 ET
- Period: 2018-06-30
- Accession: 0000066570-18-000036
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/66570/000006657018000036/a10q-q22018.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/66570/000006657018000036/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2018-04-01 to 2018-06-30 | $153.8m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2018-01-01 to 2018-06-30 | $301.2m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-04-01 to 2018-06-30 | $13.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2018-01-01 to 2018-06-30 | $26.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-04-01 to 2018-06-30 | $82.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2018-01-01 to 2018-06-30 | $162.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-04-01 to 2018-06-30 | $46.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2018-01-01 to 2018-06-30 | $91.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-04-01 to 2018-06-30 | $5.2m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2018-01-01 to 2018-06-30 | $10.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-04-01 to 2018-06-30 | $9.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2018-01-01 to 2018-06-30 | $19.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-04-01 to 2018-06-30 | $33.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2018-01-01 to 2018-06-30 | $65.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-04-01 to 2018-06-30 | $0.85 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2018-01-01 to 2018-06-30 | $1.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-04-01 to 2018-06-30 | $0.86 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2018-01-01 to 2018-06-30 | $1.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-04-01 to 2018-06-30 | 38,903,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2018-01-01 to 2018-06-30 | 38,841,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2018-01-01 to 2018-06-30 | $65.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2018-01-01 to 2018-06-30 | $8.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2018-01-01 to 2018-06-30 | $28.0m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2018-06-30 | $116.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-06-30 | $609.5m | us-gaap:AssetsCurrent |
| Total assets | at 2018-06-30 | $1.65bn | us-gaap:Assets |
| Current liabilities | at 2018-06-30 | $283.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-06-30 | $1.01bn | us-gaap:Liabilities |
| Long-term debt | at 2018-06-30 | $403.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2018-06-30 | $26.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2018-06-30 | $633.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 44,836 characters.

*The following discussion and analysis should be read in conjunction with the historical financial statements and other financial information included elsewhere in this quarterly report on Form 10-Q. This discussion may contain forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business, and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in the sections of our annual report entitled “Forward-Looking Statements” and “Risk Factors.”*

### BUSINESS OVERVIEW

We are a global leader in the development, manufacture and supply of safety products that protect people and facility infrastructures. Many MSA products integrate a combination of electronics, mechanical systems and advanced materials to protect users against hazardous or life-threatening situations. The Company's comprehensive product line is used by workers around the world in a broad range of markets, including the oil, gas and petrochemical, fire service, construction, utilities, and mining industries. MSA's core products include fixed gas and flame detection systems, breathing apparatus where self-contained breathing apparatus ("SCBA") is the principal product, portable gas detection instruments, industrial head protection products, firefighter helmets and protective apparel, and fall protection devices. We are committed to providing our customers with service unmatched in the safety industry and, in the process, enhancing our ability to provide a growing line of safety solutions for customers in key global markets.

On July 31, 2017, the Company acquired 100% of the common stock of Globe Holding Company, LLC ("Globe") for $215 million in cash plus a working capital adjustment of $1.4 million. Based in Pittsfield, NH, Globe is a leading innovator and provider of firefighter protective clothing and boots. This acquisition aligns with the Company's corporate strategy in that it strengthens our leading position in the North American fire service market. The transaction was funded through borrowings on our unsecured senior revolving credit facility. Refer to Note 15—Acquisitions to the condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further information.

We tailor our product offerings and distribution strategy to satisfy distinct customer preferences that vary across geographic regions. To best serve these customer preferences, we have organized our business into seven geographical operating segments that are aggregated into three reportable geographic segments: Americas, International and Corporate. In 2017, 62% and 38% of our net sales were made by our Americas and International segments, respectively.

*Americas*. Our largest manufacturing and research and development facilities are located in the United States. We serve our markets across the Americas with manufacturing facilities in the U.S., Mexico and Brazil. Operations in other Americas segment countries focus primarily on sales and distribution in their respective home country markets.

*International*. Our International segment includes companies in Europe, Middle East, Africa, and the Asia Pacific region, some of which are in developing regions of the world. In our largest International affiliates (in Germany, France, United Kingdom, Ireland and China), we develop, manufacture and sell a wide variety of products. In China, the products manufactured are sold primarily in the home country as well as regional markets. Operations in other International segment countries focus primarily on sales and distribution in their respective home country markets. Although some of these companies may perform limited production, most of their sales are of products manufactured in our plants in Germany, France, the U.S., United Kingdom, Ireland, Sweden and China or are purchased from third party vendors.

*Corporate*. The Corporate segment primarily consists of general and administrative expenses incurred in our corporate headquarters, costs associated with corporate development initiatives, legal expense, interest expense, foreign exchange gains or losses, and other centrally-managed costs. Corporate general and administrative costs comprise the majority of the expense in the Corporate segment.

### PRINCIPAL PRODUCTS

The following is a brief description of each of our principal product categories:

MSA's corporate strategy includes a focus on driving sales of core products where we have leading market positions and a distinct competitive advantage. Core products, as mentioned above, include fixed gas and flame detection instruments, breathing apparatus where SCBA is the principal product, portable gas detection instruments, industrial head protection products, firefighter helmets & protective apparel, and fall protection devices. These products receive the highest levels of investment and resources as they typically realize higher levels of return on investment than non-core products. Core products comprised approximately 87% and 84% of sales for the six months ended June 30, 2018 and 2017, respectively.

MSA maintains a portfolio of non-core products. Non-core products reinforce and extend the core offerings, drawing upon our customer relationships, distribution channels, geographical presence and technical experience. These products are complementary to the core offerings and have their roots within the core product value chain. Key non-core products include respirators, eye and face protection, ballistic helmets and gas masks. Ballistic helmet and gas mask sales are the primary sales to our military customers and were approximately $20.8 million and $19.0 million globally during the six months ended June 30, 2018 and 2017, respectively.

A detailed listing of our significant product offerings in the aforementioned product groups above is included in MSA's Annual Report on Form 10-K for the year ended December 31, 2017.

### RESULTS OF OPERATIONS

### Three Months Ended June 30, 2018, Compared to Three Months Ended June 30, 2017

***Net Sales.*** Net sales for the three months ended June 30, 2018, were $339.3 million, an increase of $50.5 million, or 17.5%, compared to $288.8 million for the three months ended June 30, 2017. Please refer to the Net Sales table for a reconciliation of the quarter over quarter sales change.

*(In millions)*

| Net Sales | Three Months Ended June 30, 2018 | 2017 | Dollar Increase | Percent Increase |
| --- | ---: | ---: | ---: | ---: |
| **Consolidated** | **$339.3** | **$288.8** | **$50.5** | **17.5%** |
| Americas | 215.3 | 175.0 | 40.3 | 23.0% |
| International | 124.0 | 113.8 | 10.2 | 9.0% |

| Net Sales (Percent Change) | Three Months Ended June 30, 2018 versus June 30, 2017 Americas | International | Consolidated |
| --- | ---: | ---: | ---: |
| **GAAP reported sales change** | 23.0% | 9.0% | 17.5% |
| Less: Currency translation effects | (1.5)% | 5.2% | 1.2% |
| Constant currency sales change | 24.5% | 3.8% | 16.3% |
| Less: Acquisitions | 18.5% | —% | 11.2% |
| Organic constant currency change | 6.0% | 3.8% | 5.1% |

Note: Organic constant currency sales change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Organic constant currency sales change is calculated by deducting the percentage impact from acquisitions and currency translation effects from the overall percentage change in net sales.

Net sales for the Americas segment were $215.3 million in the second quarter of 2018, an increase of $40.3 million, or 23%, compared to $175.0 million in the second quarter of 2017 on stronger core sales. During the quarter, constant currency sales in the Americas segment increased 24% compared to the prior year period, driven partially by the acquisition of Globe, which increased sales in the Americas segment by 18% in the second quarter. The 6% organic growth during the quarter was driven by growth in substantially all of our core product groups.

Net sales for the International segment were $124.0 million in the second quarter of 2018, an increase of $10.2 million, or 9%, compared to $113.8 million for the second quarter of 2017. Constant currency sales in the International segment increased 4% during the quarter as we recognized stronger core sales driven by a higher volume of portable instruments, breathing apparatus and head protection sales.

Backlog, which can fluctuate due to seasonality in our business, remains strong headed into the third quarter and is benefiting from large orders secured for breathing apparatus in the fire service market and a continued strong order pace in industrial products.

***Gross profit.*** Gross profit for the second quarter of 2018 was $153.8 million, an increase of $20.8 million, or 16%, compared to $133.0 million for the second quarter of 2017. The ratio of gross profit to net sales was 45.3% in the second quarter of 2018 compared to 46.0% in the same quarter last year. The lower gross profit ratio during the current quarter is primarily attributable to dilution from our Globe acquisition as well as higher raw materials costs and quarter specific indirect costs related to customer experience. These impacts were partially offset by price realization from new product introductions.

***Selling, general and administrative expenses.*** Selling, general and administrative ("SG&A") expenses were $82.0 million during the second quarter of 2018, an increase of $7.9 million or 10.6%, compared to $74.1 million in the second quarter of 2017. The increase is primarily related to increased SG&A expenses related to the Globe acquisition, selling costs to invest in resources to drive revenue growth, bad debt expense related to a customer bankruptcy and health care costs related to unfavorable claims experience during the period. Overall, selling, general and administrative expenses were 24.2% of net sales in the second quarter of 2018, compared to 25.7% of net sales in the second quarter of 2017. Please refer to the Selling, general and administrative expenses table for a reconciliation of the year over year expense change.

| Selling, general, and administrative expenses (Percent Change) | Three Months Ended June 30, 2018 versus June 30, 2017 Consolidated |
| --- | ---: |
| GAAP reported change | 10.6% |
| Less: Currency translation effects | 0.8% |
| Constant currency change | 9.8% |
| Less: Acquisitions and related strategic transaction costs | 1.6% |
| Organic constant currency change | 8.2% |

Note: Organic constant currency change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Constant currency change in selling, general, and administrative expenses is calculated by deducting the percentage impact from acquisitions and related strategic transaction costs as well as the currency translation effects from the overall percentage change in selling, general, and administrative expense. Management believes excluding acquisitions and currency translation effects provides investors with a greater level of clarity into spending levels on a year-over-year basis.

***Research and development expense.*** Research and development expense was $13.9 million during the second quarter of 2018, an increase of $2.0 million, or 17%, compared to $11.9 million during the second quarter of 2017. Research and development expense was 4.1% of net sales in both the second quarter of 2018 and 2017. We expect research and development expense to be approximately 4.0% of sales for 2018 as we continue to develop new products for global safety markets.

***Restructuring, net of adjustments.*** During the second quarter of 2018, the Company recorded restructuring charges of $2.3 million, primarily related to severance costs for staff reductions associated with our ongoing initiatives to drive profitable growth in Europe and ongoing review of the Company's legal structure to evaluate potential realignments to better facilitate the execution of our corporate strategy. This compared to restructuring charges of $1.0 million during the second quarter of 2017, primarily related to severance costs for staff reductions associated with our ongoing initiatives to right size our operations in Europe and Africa.

***Currency exchange.*** Currency exchange losses were $0.8 million in the second quarter of 2018, compared to $2.9 million in the second quarter of 2017. Currency exchange losses in both periods were related to foreign currency exposure on unsettled inter-company balances. Refer to Note 17—Derivative Financial Instruments to the unaudited condensed consolidated financial statements in Part I Item I of this Form 10-Q, for information regarding our currency exchange rate risk management strategy.

***Other operating expense.*** Other operating expense during the second quarter of 2018 was $8.0 million, relates primarily to defense costs for uninsured asserted cumulative trauma product liability claims as well as an adjustment to our estimated insurance receivables to be collected under our Coverage-In-Place agreements as we obtained further information on the claims composition of the settlements reached in August 2017. This compared to $29.6 million in the second quarter of 2017, primarily related to certain asserted cumulative trauma product liability claims which MSA LLC agreed to resolve in August 2017. These charges are related to legacy products designed, manufactured and sold many years ago and are not currently sold by the Company. Please refer to Note 19—Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for additional information.

***GAAP operating income.*** Consolidated operating income for the second quarter of 2018 was $46.8 million compared to operating income of $13.5 million in the same period last year. The increase in operating results was primarily driven by higher sales volumes as discussed above as well as lower other operating expenses.

***Adjusted operating income.*** Americas adjusted operating income for the second quarter of 2018 was $49.8 million, an increase of $6.2 million, or 14%, compared to $43.6 million in the prior year quarter. The increase was related to the higher level of sales, partially offset by higher selling, general and administrative expenses and increased investments in research and development.

International adjusted operating income for the second quarter of 2018 was $15.9 million, an increase of $3.8 million, or 31%, compared to $12.1 million in the prior year quarter. The increase in adjusted operating income is primarily attributable to higher sales volumes and improvements associated with our ongoing initiatives to right size our operations in Europe.

Corporate segment adjusted operating loss for the second quarter of 2018 was $7.7 million, an increase of $0.6 million, or 8%, compared to an adjusted operating loss of $7.1 million in the second quarter of 2017 reflecting higher variable compensation expense partially offset by lower legal expenses.

The following tables represent a reconciliation from GAAP operating income to adjusted operating income (loss). Adjusted operating margin % is calculated as adjusted operating income (loss) divided by net sales.

*(In thousands)*

| Adjusted operating income | Three Months Ended June 30, 2018 Americas | International | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $215,339 | $123,992 | $— | $339,331 |
| GAAP operating income |  |  |  | 46,797 |
| Restructuring charges (Note 5) |  |  |  | 2,335 |
| Currency exchange losses, net |  |  |  | 815 |
| Other operating expense (Note 19) |  |  |  | 8,018 |
| Strategic transaction costs (Note 15) |  |  |  | 58 |
| Adjusted operating income (loss) | 49,838 | 15,853 | (7,668) | 58,023 |
| Adjusted operating margin % | 23.1% | 12.8% |  |  |

*(In thousands)*

| Adjusted operating income | Three Months Ended June 30, 2017 Americas | International | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $174,960 | $113,815 | — | $288,775 |
| GAAP operating income |  |  |  | 13,498 |
| Restructuring and other charges |  |  |  | 967 |
| Currency exchange gains, net |  |  |  | 2,851 |
| Other operating expense (Note 19) |  |  |  | 29,610 |
| Strategic transaction costs (Note 15) |  |  |  | 1,642 |
| Adjusted operating income (loss) | 43,573 | 12,122 | (7,127) | 48,568 |
| Adjusted operating margin % | 24.9% | 10.7% |  |  |

Note: Adjusted operating income (loss) is a non-GAAP financial measure used by the chief operating decision maker to evaluate segment performance and allocate resources. Adjusted operating income (loss) is reconciled above to the nearest GAAP financial measure, Operating income (loss), and excludes restructuring, currency exchange, other operating expense and strategic transaction costs.

***Total other expense, net.*** Other expense, net, for the second quarter of 2018 was $3.5 million, compared to $1.8 million for the same period in 2017.

***Income taxes.*** The reported effective tax rate for the second quarter of 2018 was 22.8%, which included 2.2% of a tax benefit for certain share-based payments related to the application of ASU 2016-09 as described in Note 2—Recently Adopted and Recently Issued Accounting Standards to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q, compared to a benefit of 7.7% for the second quarter of 2017, which included 34.4% of a tax benefit related to share-based payments. The remaining effective tax rate change was primarily due to the decrease in the U.S. federal statutory rate. This decrease was partially offset due to increased profitability in less favorable tax jurisdictions and higher foreign entity losses in jurisdictions where we cannot take tax benefits.

***Net income attributable to MSA Safety Incorporated.*** Net income was $33.2 million for the second quarter of 2018, or $0.85 per diluted share compared to income of $12.5 million, or $0.32 per diluted share, for the same period last year.

### Six Months Ended June 30, 2018, Compared to Six Months Ended June 30, 2017

***Net Sales.*** Net sales for the six months ended June 30, 2018, were $665.2 million, an increase of $110.7 million, or 20%, compared to $554.5 million for the six months ended June 30, 2017. Please refer to the Net Sales table for a reconciliation of the quarter over quarter sales change.

*(In millions)*

| Net Sales | Six Months Ended June 30, 2018 | 2017 | Dollar Increase | Percent Increase |
| --- | ---: | ---: | ---: | ---: |
| **Consolidated** | **$665.2** | **$554.5** | **$110.7** | **20.0%** |
| Americas | 424.5 | 341.5 | 83.0 | 24.3% |
| International | 240.7 | 213.0 | 27.7 | 13.0% |

| Net Sales (Percent Change) | Six Months Ended June 30, 2018 versus June 30, 2017 Americas | International | Consolidated |
| --- | ---: | ---: | ---: |
| **GAAP reported sales change** | 24.3% | 13.0% | 20.0% |
| Less: Currency translation effects | (0.6)% | 8.2% | 2.9% |
| Constant currency sales change | 24.9% | 4.8% | 17.1% |
| Less: Acquisitions | 17.9% | —% | 11.0% |
| Organic constant currency change | 7.0% | 4.8% | 6.1% |

Note: Organic constant currency sales change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Organic constant currency sales change is calculated by deducting the percentage impact from acquisitions and currency translation effects from the overall percentage change in net sales.

Net sales for the Americas segment were $424.5 million for the six months ended June 30, 2018, an increase of $83.0 million, or 24.3%, compared to $341.5 million for the same period in 2017 on stronger core sales. During the six months ended June 30, 2018, constant currency sales in the Americas segment increased 25% compared to the prior year period, driven partially by the acquisition of Globe, which increased sales in the Americas segment by 18% during the period. The 7% organic growth during the six months ended June 30, 2018, was driven by growth in substantially all of our core product groups.

Net sales for the International segment were $240.7 million for the six months ended June 30, 2018, an increase of $27.7 million, or 13.0%, compared to $213.0 million for the same period in 2017. During the six months ended June 30, 2018, constant currency sales in the International segment increased 5% during the quarter as we recognized stronger core sales driven by growth in substantially all of our core product groups.

***Gross profit.*** Gross profit for the six months ended June 30, 2018, was $301.2 million, an increase of $48.5 million, or 19.2%, compared to $252.7 million for the same period in 2017. The ratio of gross profit to net sales was 45.3% during the six months ended June 30, 2018, compared to 45.6% in the same period last year. The lower gross profit ratio during the current period is primarily attributable to dilution from our Globe acquisition as well as quarter specific indirect costs related to customer experience. These impacts were partially offset by price realization from new product introductions.

***Selling, general and administrative expenses.*** Selling, general and administrative expenses were $162.2 million during the six months ended June 30, 2018, an increase of $11.3 million or 7.5%, compared to $150.9 million during the same period in 2017. The increase is primarily related to increased SG&A expenses related to the Globe acquisition, selling costs to invest in resources to drive revenue growth, bad debt expense related to a customer bankruptcy and health care costs related to unfavorable claims experience during the period. Overall, selling, general and administrative expenses were 24.4% of net sales during the six months ended June 30, 2018, compared to 27.2% of net sales during the same period in 2017, reflecting the continued benefits from our global cost reduction program and our focus on driving profitable growth. Please refer to the Selling, general and administrative expenses table for a reconciliation of the year over year expense change.

| Selling, general, and administrative expenses (Percent Change) | Six Months Ended June 30, 2018, versus June 30, 2017 Consolidated |
| --- | ---: |
| GAAP reported change | 7.5% |
| Less: Currency translation effects | 1.6% |
| Constant currency change | 5.9% |
| Less: Acquisitions and related strategic transaction costs | 1.8% |
| Organic constant currency change | 4.1% |

Note: Organic constant currency change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Constant currency change in selling, general, and administrative expenses is calculated by deducting the percentage impact from acquisitions and related strategic transaction costs as well as the currency translation effects from the overall percentage change in selling, general, and administrative expense. Management believes excluding acquisitions and currency translation effects provides investors with a greater level of clarity into spending levels on a year-over-year basis.

***Research and development expense.*** Research and development expense was $26.5 million during the six months ended June 30, 2018, an increase of $3.5 million, or 15.4%, compared to $22.9 million during the same period in 2017. Research and development expense was 4.0% of net sales during the six months ended June 30, 2018, compared to 4.1% of net sales during the same period in 2017. We expect research and development expense to be approximately 4.0% of sales for 2018 as we continue to develop new products for global safety markets.

***Restructuring, net of adjustments.*** During the six months ended June 30, 2018, the Company recorded restructuring charges of $7.6 million, primarily related to severance costs for staff reductions associated with our ongoing initiatives to drive profitable growth in Europe and the ongoing review of the Company's legal structure to evaluate potential realignments to better facilitate the execution of our corporate strategy. This compared to restructuring charges of $13.7 million during the same period in 2017, primarily related to noncash special termination benefit expense of $11.4 million for the voluntary retirement incentive package elected by certain employees in the Americas segment.

***Currency exchange.*** Currency exchange losses were $2.8 million in the six months ended June 30, 2018, compared to $3.4 million during the same period in 2017. Currency exchange losses in both periods were related to foreign currency exposure on unsettled inter-company balances. Refer to Note 17—Derivative Financial Instruments to the unaudited condensed consolidated financial statements in Part I Item I of this Form 10-Q, for information regarding our currency exchange rate risk management strategy.

***Other operating expense.*** Other operating expense for the six months ended June 30, 2018, was $10.8 million, primarily related to defense costs for uninsured asserted cumulative trauma product liability claims as well as an adjustment to our estimated insurance receivables to be collected under our Coverage-In-Place agreements as we obtained further information on the claims composition of the settlements reached in August 2017. This compared to $29.6 million during the same period in 2017, primarily related to certain asserted cumulative trauma product liability claims which MSA LLC agreed to resolve in August 2017. These charges are related to legacy products designed, manufactured and sold many years ago and are not currently sold by the Company. Please refer to Note 19—Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for additional information.

***GAAP operating income.*** Consolidated operating income for the six months ended June 30, 2018, was $91.2 million compared to operating income of $32.1 million in the same period in 2017. The increase in operating results was primarily driven by higher sales volumes as discussed above as well as lower restructuring and other operating expense and our continued focus on controlled spending.

***Adjusted operating income.*** Americas adjusted operating income for the six months ended June 30, 2018, was $99.9 million, an increase of $20.2 million, or 25%, compared to $79.7 million during the same period in 2017. The increase was related to the higher level of sales as well as our continued focus on controlled spending.

International adjusted operating income for the six months ended June 30, 2018, was $28.6 million, an increase of $8.7 million, or 44%, compared to $19.9 million during the same period in 2017. The increase in adjusted operating income is primarily attributable to higher sales volumes and our ongoing initiatives to right size our operations in Europe.

Corporate segment adjusted operating loss for the six months ended June 30, 2018, was $15.9 million, a decrease of $1.9 million, or 11%, compared to an adjusted operating loss of $17.8 million during the same period in 2017, reflecting lower stock compensation and legal expense.

The following tables represent a reconciliation from GAAP operating income to adjusted operating income (loss). Adjusted operating margin % is calculated as adjusted operating income (loss) divided by net sales.

*(In thousands)*

| Adjusted operating income | Six Months Ended June 30, 2018 Americas | International | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $424,468 | $240,757 | $— | $665,225 |
| GAAP operating income |  |  |  | 91,232 |
| Restructuring charges (Note 5) |  |  |  | 7,609 |
| Currency exchange losses, net |  |  |  | 2,823 |
| Other operating expense (Note 19) |  |  |  | 10,842 |
| Strategic transaction costs (Note 15) |  |  |  | 152 |
| Adjusted operating income (loss) | 99,924 | 28,631 | (15,897) | 112,658 |
| Adjusted operating margin % | 23.5% | 11.9% |  |  |

*(In thousands)*

| Adjusted operating income | Six Months Ended June 30, 2017 Americas | International | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $341,528 | $213,012 | — | $554,540 |
| GAAP operating income |  |  |  | 32,117 |
| Restructuring and other charges |  |  |  | 13,706 |
| Currency exchange gains, net |  |  |  | 3,431 |
| Other operating expense (Note 19) |  |  |  | 29,610 |
| Strategic transaction costs (Note 15) |  |  |  | 2,979 |
| Adjusted operating income (loss) | 79,724 | 19,918 | (17,799) | 81,843 |
| Adjusted operating margin % | 23.3% | 9.4% |  |  |

Note: Adjusted operating income (loss) is a non-GAAP financial measure used by the chief operating decision maker to evaluate segment performance and allocate resources. Adjusted operating income (loss) is reconciled above to the nearest GAAP financial measure, Operating income (loss), and excludes restructuring, currency exchange, other operating expense and strategic transaction costs.

***Total other expense, net.*** Other expense, net, during the six months ended June 30, 2018, was $5.9 million, compared to $3.9 million during the same period in 2017.

***Income taxes.*** The reported effective tax rate for the six months ended June 30, 2018, was 22.7%, which included 2.2% of a tax benefit for certain share-based payments related to the application of ASU 2016-09 as described in Note 2 to the condensed consolidated financial statements in Part I Item 1 of this Form 10-Q, compared to 3.2% for the same period in 2017, which included 24.2% of a tax benefit related to share-based payments. The remaining effective tax rate change was primarily due to the decrease in the U.S. federal statutory rate. This decrease was partially offset due to increased profitability in less favorable tax jurisdictions and higher foreign entity losses in jurisdictions where we cannot take tax benefits.

On December 22, 2017, SAB 118 was issued to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared or analyzed in reasonable detail to complete the accounting for certain income tax effects of the Act. In accordance with SAB 118, the Company calculated its best estimate of the impact of the Act during the fourth quarter of 2017 and we have made no adjustment to those amounts during the six months ended June 30, 2018. Changes to applicable tax law, regulations or interpretations of the Act may require further adjustments and changes in our estimates. The final determination of the transition tax and the revaluation of U.S. deferred assets and liabilities will be completed as additional information becomes available, but no later than one year from the enactment of the Act.

***Net income attributable to MSA Safety Incorporated.*** Net income was $65.6 million for the six months ended June 30, 2018, or $1.69 per diluted share compared to income of $26.9 million, or $0.70 per diluted share, for the same period last year.

### Non-GAAP Financial Information

We may provide information regarding organic constant currency changes, financial measures excluding the impact of acquisitions and related strategic transaction costs, adjusted operating income, and adjusted operating margin percentage which are not recognized terms under U.S. GAAP and do not purport to be alternatives to net sales, selling, general and administrative expense, operating income, or net income as a measure of operating performance. We believe that the use of these non-GAAP financial measures provide investors with additional useful information and provide a more complete understanding of the underlying results. Because not all companies use identical calculations, these presentations may not be comparable to similarly titled measures from other companies. For more information about these non-GAAP measures and a reconciliation to the nearest U.S. GAAP measure, please refer to the reconciliations referenced above in Management's Discussion & Analysis section and in Note 9—Segment Information to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q.

We may also provide financial information on a constant currency basis, which is a non-GAAP financial measure. These references to a constant currency basis do not include operational impacts that could result from fluctuations in foreign currency rates, which are outside of management's control. To provide information on a constant currency basis, the applicable financial results are adjusted by translating current and prior period results in local currency to a fixed foreign exchange rate. This approach is used for countries where the functional currency is the local country currency. This information is provided so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby facilitating period-to-period comparisons of business performance. Constant currency information is not recognized under U.S. GAAP, and it is not intended as an alternative to U.S. GAAP measures.

### LIQUIDITY AND CAPITAL RESOURCES

Our main source of liquidity is operating cash flows, supplemented by borrowings. Our principal liquidity requirements are for working capital, capital expenditures, principal and interest payments on debt, dividend payments and acquisitions. At June 30, 2018, approximately 42% of our long-term debt is at fixed interest rates with repayment schedules through 2031. The remainder of our long-term debt is at variable rates on an unsecured revolving credit facility that is due in 2020. At June 30, 2018, approximately 82% of our borrowings are denominated in US dollars, which limits our exposure to currency exchange rate fluctuations.

At June 30, 2018, we had cash, cash equivalents and restricted cash totaling $119.9 million, which included $97.5 million of cash and cash equivalents held by our foreign subsidiaries. Cash, cash equivalents and restricted cash decreased $18.0 million during the six months ended June 30, 2018, compared to increasing $1.3 million during the same period in 2017. During the six months ended June 30, 2018, we repatriated $54 million of cash from our foreign affiliates and expect to repatriate an additional $21 million - $46 million in the second half of 2018. While cash repatriation allows us to tap into our offshore cash more efficiently, our business continues to generate strong cash flow, and this improvement in cash flow has enabled us to continue to de-lever. In July 2018, we reached a settlement on the disputed portion of our insurance receivable as discussed in Note 19—Contingencies. The settlement ensures collection of the full amount of the insurance receivable that was previously subject to litigation. Payment is expected to be received in the third quarter of 2018. We plan to continue to employ a balanced capital allocation strategy that prioritizes growth investments and also funding our dividend and servicing debt obligations.

***Operating activities.*** Operating activities provided cash of $65.4 million during the six months ended June 30, 2018, compared to providing $146.3 million during the same period in 2017. The decrease in operating cash flows during the period was primarily attributable to lower insurance receivable collections. We paid $7.7 million in product liability settlements, net of collections from insurance companies, in the six months ended June 30, 2018, while we collected $93.5 million from insurance companies, net of product liability settlements paid, in the same period of 2017. Historically, cumulative trauma liability payments were funded with the Company's operating cash flow, pending resolution of disputed insurance coverage. For more than a decade, we have funded product liability settlements from operating cash flow. We continue to make good progress collecting insurance proceeds and establishing cash flow streams for the future. We expect to receive $80 million in the third quarter of 2018 from all previously settled insurance policies. Although cash flows may vary from quarter to quarter, we do not expect there to be a material impact on our capital allocation priorities.

The amount recorded in connection with the cumulative trauma product liability settlements reached in August 2017 totaling $75.2 million as discussed in Note 19—Contingencies to the unaudited condensed consolidated financial statements and remaining asserted cumulative trauma claims did not have a significant cash impact in the six months ended June 30, 2018. The Company made payments of $25.2 million in the third and fourth quarters of 2017 related to these settlements. The Company paid $14.3 million in the second quarter related to these settlements and the balance is expected to be paid ratably over the next five quarters, ending in the third quarter of 2019. At June 30, 2018, $39.0 million of the total $162.3 million reserve relates to settlements and related defense costs. The remaining reserve consists of $107.8 million related to a liability for incurred but not reported ("IBNR") cumulative trauma product liability claims and $15.5 million related primarily to estimated indemnity for all other remaining asserted cumulative trauma product liability claims that are probable and estimable at June 30, 2018. Please refer to Note 19—Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for additional information.

***Investing activities.*** Investing activities used cash of $5.8 million during the six months ended June 30, 2018, compared to using $5.5 million during the same period in 2017. Capital expenditures drove cash outflows from investing activities during both periods.

***Financing activities.*** Financing activities used cash of $69.5 million during the six months ended June 30, 2018, compared to using $142.9 million during the same period in 2017. During the six months ended June 30, 2018, we had net payments on long-term debt of $42.5 million as compared to net payments of $124.8 million during the same period in 2017. We paid cash dividends of $28.0 million during the six months ended June 30, 2018, compared to $25.8 million in the same period in 2017.

In July 2018, we provided notice of repayment to the holders of our 5.41% 2006 Senior Notes, which totaled $26.7 million at June 30, 2018. The total amount repaid will include approximately $1.2 million related to a make-whole provision and accrued interest through the date of repayment. This amount will be refined prior to repayment which we expect to occur by the end of August 2018 using borrowings on our senior revolving credit facility with an average interest rate of 3.31%. At June 30, 2018, $316.7 million of the existing $575.0 million senior revolving credit facility was unused, including letters of credit.

### CUMULATIVE TRANSLATION ADJUSTMENTS

The position of the U.S. dollar relative to international currencies at June 30, 2018, resulted in a translation loss of $14.4 million being recorded to the cumulative translation adjustments shareholders' equity account during the six months ended June 30, 2018, compared to a gain of $26.3 million during the same period in 2017. The translation loss during the six months ended June 30, 2018, was primarily related to the strengthening of the U.S. dollar relative to the euro and Mexican peso. The translation gain during the six months ended June 30, 2017, was primarily related to the strengthening of the euro, British pound, and Mexican peso relative to the U.S. dollar.

Inflation in Argentina in the second quarter of 2018 increased at an accelerated rate and effective June 30, 2018, Argentina’s economy is considered highly inflationary. Beginning July 1, 2018, under a highly-inflationary basis of accounting, the Company’s monetary assets (such as cash and receivables) and monetary liabilities (such as payables and accruals) at its operations in Argentina will be remeasured at the end of each reporting period with such entries recorded to the income statement rather than to accumulated other comprehensive loss on the balance sheet. Because the Argentinian peso is subject to fluctuation, such remeasurement would increase the volatility of reported results of operations in future periods. However, the Company has a small presence in Argentina with only one plant in that country, so the impact from the highly-inflationary basis of accounting is not expected to be material.

### COMMITMENTS AND CONTINGENCIES

We made contributions of $2.5 million to our pension plans during the six months ended June 30, 2018. We expect to make total contributions of approximately $5.0 million to our pension plans in 2018 which are primarily associated with our International segment.

The Company had outstanding bank guarantees and standby letters of credit with banks as of June 30, 2018, totaling $15.1 million, of which $6.2 million related to the senior revolving credit facility. These letters of credit serve to cover customer requirements in connection with certain sales orders and insurance companies. No amounts were drawn on these arrangements at June 30, 2018. The Company is also required to provide cash collateral in connection with certain arrangements. At June 30, 2018, the Company has $3.2 million of restricted cash in support of these arrangements.

We have purchase commitments for materials, supplies, services, and property, plant and equipment as part of our ordinary conduct of business.

Please refer to Note 19—Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further discussion on the Company's product liabilities.

### CRITICAL ACCOUNTING POLICIES AND ESTIMATES

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. We evaluate these estimates and judgments on an on-going basis based on historical experience and various assumptions that we believe to be reasonable under the circumstances. However, different amounts could be reported if we had used different assumptions and in light of different facts and circumstances. Actual amounts could differ from the estimates and judgments reflected in our consolidated financial statements.

The more critical judgments and estimates used in the preparation of our consolidated financial statements are discussed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2017.

Refer to Note 3—Significant Accounting Policies Update to the unaudited condensed consolidated financial statements for an update to the accounting policy for revenue recognition as a result of the adoption of 2014-09, *Revenue with Contracts from Customers,* on January 1, 2018.

Effective December 31, 2017, the Company changed the method it uses to estimate the service and interest cost components of net periodic benefit cost for pension and other post-retirement benefits for a majority of its U.S. and foreign plans. Historically, the service and interest cost components for these plans were estimated using a single weighted-average discount rate derived from the yield curve used to measure the projected benefit obligation at the beginning of the period. The Company has elected to utilize a spot rate approach, which discounts the individual plan specific expected cash flows underlying the service and interest cost using the applicable spot rates derived from a yield curve used in the determination of the benefit obligation to the relevant projected cash flows. Refer to Note 16—Pensions and Other Post-retirement Benefits to the unaudited condensed consolidated financial statements for additional information.

### RECENTLY ADOPTED AND RECENTLY ISSUED ACCOUNTING STANDARDS

Please refer to Note 2— Recently Adopted and Recently Issued Accounting Standards to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q.

## Market risk

As filed, 2,441 characters.

Market risk represents the risk of adverse changes in the value of a financial instrument caused by changes in currency exchange rates, interest rates, and equity prices. We are exposed to market risks related to currency exchange rates and interest rates.

***Currency exchange rate sensitivity.*** We are subject to the effects of fluctuations in currency exchange rates on various transactions and on the translation of the reported financial position and operating results of our non-U.S. companies from local currencies to U.S. dollars. A hypothetical 10% strengthening or weakening of the U.S. dollar would decrease or increase our reported sales and net income by approximately $15.2 million or 4.5% and $1.6 million or 4.9%, respectively, for the three months ended June 30, 2018.

When appropriate, we may attempt to limit our transactional exposure to changes in currency exchange rates through contracts or other actions intended to reduce existing exposures by creating offsetting currency exposures. At June 30, 2018, we had open foreign currency forward contracts with a U.S. dollar notional value of $71.0 million. A hypothetical 10% increase in June 30, 2018, forward exchange rates would result in a $7.1 million increase in the fair value of these contracts.

***Interest rates.*** We are exposed to changes in interest rates primarily as a result of borrowing and investing activities used to maintain liquidity and fund business operations. Because of the relatively short maturities of temporary investments, these financial instruments are reported at carrying values that approximate fair values.

At June 30, 2018, we had $179.2 million of fixed rate debt which matures at various dates through 2031. The incremental increase in the fair value of fixed rate long-term debt resulting from a hypothetical 10% decrease in interest rates would be approximately $12.6 million. However, our sensitivity to interest rate declines and the corresponding increase in the fair value of our debt portfolio would unfavorably affect earnings and cash flows only to the extent that we elected to repurchase or retire all or a portion of our fixed rate debt portfolio at prices above carrying values.

At June 30, 2018, we had $252.2 million of variable rate borrowings under our revolving credit facility. A 100 basis point increase or decrease in interest rates could impact our future earnings under our current capital structure.

## Controls and procedures

As filed, 1,167 characters.

(a) *Evaluation of disclosure controls and procedures.* Based on their evaluation as of the end of the period covered by this Form 10-Q, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and (ii) accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding disclosure.

(b) *Changes in internal control*. There were no changes in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 4,082 characters.

**Claims of injuries from our products, product defects or recalls of our products could have a materially adverse effect on our business, operating results, financial condition and liquidity.**

MSA and its subsidiaries face an inherent business risk of exposure to product liability claims arising from the alleged failure of our products to prevent the types of personal injury or death against which they are designed to protect. In the event the parties using our products are injured or any of our products prove to be defective, we could be subject to claims with respect to such injuries. In addition, we may be required to or may voluntarily recall or redesign certain products that could potentially be harmful to end users. Any claim or product recall that results in significant expense or negative publicity against us could have a material adverse effect on our business, operating results, financial condition and liquidity, including any successful claim brought against us in excess or outside of available insurance coverage.

**Our subsidiary, Mine Safety Appliances Company, LLC, may experience losses from cumulative trauma product liability claims. The inability to collect insurance receivables and the transition to becoming largely self-insured for cumulative trauma product liability claims could have a material adverse effect on our business, operating results, financial condition and liquidity.**

Our subsidiary, Mine Safety Appliances Company, LLC (“MSA LLC”) was named as a defendant in 1,470 cumulative trauma lawsuits comprised of 2,345 claims at June 30, 2018. Cumulative trauma product liability claims involve exposures to harmful substances (e.g., silica, asbestos and coal dust) that occurred years ago and may have developed over long periods of time into diseases such as silicosis, asbestosis, mesothelioma or coal worker’s pneumoconiosis. The products at issue were manufactured many years ago and are not currently offered by MSA LLC. A reserve has been established with respect to cumulative trauma product liability claims currently asserted and estimated incurred but not reported (“IBNR”) cumulative trauma product liability claims. Because our cumulative trauma product liability risk is subject to inherent uncertainties, including unfavorable trial rulings or developments, an increase in newly filed claims, or more aggressive settlement demands, and since MSA LLC is largely self-insured, there can be no certainty that MSA LLC may not ultimately incur losses in excess of presently recorded liabilities. These losses could have a material adverse effect on our business, operating results, financial condition and liquidity. We will adjust the reserve relating to cumulative trauma product liability claims from time to time based on whether the actual numbers, types and settlement values of claims asserted differ from current projections and estimates or there are significant changes in the facts underlying the assumptions used in establishing the reserve. These adjustments may be material and could materially impact future periods in which the reserve is adjusted.

In the normal course of business, MSA LLC makes payments to settle these types of cumulative trauma product liability claims and for related defense costs, and records receivables for the estimated amounts believed to be recoverable under insurance. MSA LLC has recorded insurance receivables totaling $125.7 million and notes receivables of $63.8 million at June 30, 2018. Since MSA LLC is now largely self-insured for cumulative trauma claims, additional amounts recorded as insurance receivables will be limited and based on calculating the amounts to be reimbursed pursuant to negotiated Coverage-in-Place Agreements. Various factors could affect the timing and amount of recovery of the insurance receivable, including assumptions regarding claims composition (which are relevant to calculating reimbursement under the terms of certain Coverage-In-Place Arrangements) and the extent to which the issuing insurers may become insolvent in the future.

Filed Jul 26, 2018.
Source: SEC EDGAR, the filing index for accession 0000066570-18-000036. Last ingested by Listed: Nov 3, 2026, 21:35 ET. No prices; not investment advice.
